Literature DB >> 7915518

Somatostatin-14 increases the inositol-1,4,5-trisphosphate content in various areas of the brain.

A Lachowicz1, M Pawlikowski, T Ochedalski.   

Abstract

The effects of somatostatin-14 on inositol-1,4,5-trisphosphate (IP3) content were examined in rat pituitary, hippocampus and cortex homogenates. Somatostatin increased IP3 concentration in all these investigated regions in a dose- and time-dependent manner. Maximal increase of IP3 content was found in the pituitary homogenate, and in the hippocampal and cortex homogenates the IP3 argumentation was slightly smaller. Time-response studies showed that this effect declined with extended time of incubation. These results suggest that IP3 is involved in the mechanism of action of somatostatin in brain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7915518     DOI: 10.1006/bbrc.1994.2193

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Comparison of functional profiles at human recombinant somatostatin sst2 receptor: simultaneous determination of intracellular Ca2+ and luciferase expression in CHO-K1 cells.

Authors:  Caroline Nunn; Davide Cervia; Daniel Langenegger; Laurent Tenaillon; Rochdi Bouhelal; Daniel Hoyer
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

2.  Somatostatin-induced control of cytosolic free calcium in pituitary tumour cells.

Authors:  C Petrucci; D Cervia; M Buzzi; C Biondi; P Bagnoli
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

3.  In vitro effects of methionine-enkephalin, somatostatin and insulin on cultured gonadal cells of the snail Helix aspersa.

Authors:  Z Monnier; M Bride
Journal:  Experientia       Date:  1995-08-16

4.  Operational characteristics of somatostatin receptors mediating inhibitory actions on rat locus coeruleus neurones.

Authors:  I P Chessell; M D Black; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.